We are live on ! Find out more
VBA

Van Berkom & Associates Portfolio holdings

AUM $3.08B
1-Year Est. Return 12.07%
This Fund
S&P 500
This Quarter Est. Return
+16.92%
1 Year Est. Return
+12.07%
3 Year Est. Return
+35.5%
5 Year Est. Return
+48.97%
10 Year Est. Return
+344.82%
AUM
$3.15B
AUM Growth
+$322M
Cap. Flow
-$74.4M
Cap. Flow %
-2.36%
Top 10 Hldgs %
31.92%
Holding
62
New
3
Increased
14
Reduced
42
Closed
2

Sector Composition

Rank Sector Weight
1 Industrials 23.89%
2 Financials 16.94%
3 Consumer Discretionary 15.34%
4 Healthcare 12.49%
5 Technology 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLCA
26
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$64.1M 2.03%
3,694,474
-46,738
-1% -$670K
HMSY
27
DELISTED
HMS Holdings Corp.
HMSY
$62.7M 1.99%
2,116,046
-190,432
-8% -$5.88M
MLKN icon
28
MillerKnoll
MLKN
$1.61B
$62.6M 1.99%
1,779,643
-56,146
-3% -$1.96M
RLI icon
29
RLI Corp
RLI
$5.97B
$61.2M 1.94%
1,706,674
-28,246
-2% -$973K
SLAB icon
30
Silicon Laboratories
SLAB
$7.17B
$60.3M 1.91%
746,067
-8,391
-1% -$698K
TCF
31
DELISTED
TCF Financial Corporation
TCF
$58.1M 1.84%
2,808,059
-36,222
-1% -$790K
BID
32
DELISTED
Sotheby's
BID
$58.1M 1.84%
1,538,655
-19,222
-1% -$771K
CIGI icon
33
Colliers International
CIGI
$5.31B
$57.6M 1.83%
862,407
-2,828
-0.3% -$181K
AZZ icon
34
AZZ Inc
AZZ
$4.41B
$56.8M 1.8%
1,387,672
-17,384
-1% -$769K
TVTY
35
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$56M 1.77%
3,187,318
+1,045,864
+49% +$22.3M
PRIM icon
36
Primoris Services
PRIM
$4.28B
$55.1M 1.75%
2,663,083
-33,200
-1% -$698K
HCSG icon
37
Healthcare Services Group
HCSG
$1.63B
$53.2M 1.69%
1,613,598
+352,162
+28% +$13.5M
UHS icon
38
Universal Health Services
UHS
$10.1B
$53M 1.68%
396,264
-6,686
-2% -$880K
THO icon
39
Thor Industries
THO
$4.13B
$51.7M 1.64%
829,632
+84,648
+11% +$5.36M
REVG
40
DELISTED
REV Group
REVG
$50.7M 1.61%
4,625,832
-38,671
-0.8% -$350K
WDR
41
DELISTED
Waddell & Reed Financial, Inc.
WDR
$45.1M 1.43%
2,606,279
-34,569
-1% -$609K
DXPE icon
42
DXP Enterprises
DXPE
$2.49B
$44.5M 1.41%
1,143,977
+41,901
+4% +$1.46M
TCX icon
43
Tucows
TCX
$101M
$33.9M 1.07%
423,849
-224,034
-35% -$16.3M
ELLI
44
DELISTED
Ellie Mae Inc
ELLI
$31M 0.98%
314,449
-459,753
-59% -$39.9M
STN icon
45
Stantec
STN
$8.19B
$30.4M 0.96%
1,286,025
-4,254
-0.3% -$101K
ORA icon
46
Ormat Technologies
ORA
$6.05B
$16.8M 0.53%
+305,319
New +$16.9M
ARA
47
DELISTED
American Renal Associates Holdings, Inc
ARA
$16.5M 0.52%
2,689,168
-78,371
-3% -$908K
HLI icon
48
Houlihan Lokey
HLI
$10.2B
$12.1M 0.38%
+262,863
New +$11.6M
TCOM icon
49
Trip.com Group
TCOM
$28.5B
$5.03M 0.16%
115,051
-10,696
-9% -$375K
VIPS icon
50
Vipshop
VIPS
$7.13B
$2.65M 0.08%
330,250
+13,212
+4% +$93.6K

Similar funds

Van Berkom & Associates's Q1 2019 Portfolio in Review

As of Q1 2019, Van Berkom & Associates held 62 positions worth $3.15B, up 11% from $2.83B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Van Berkom & Associates's Q1 2019 filing shows 3 new, 14 increased, 42 reduced and 2 closed positions. Its largest new stake was Ormat Technologies: 305,319 shares worth $16.8M. The largest sale was Ellie Mae Inc, an estimated $39.9M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, down from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Van Berkom & Associates's largest Q1 2019 buy was Ormat Technologies: 305,319 shares worth $16.8M.
  • Van Berkom & Associates added most to Tivity Health, Inc. Common Stock in Q1 2019, an estimated $22.3M increase.
  • Van Berkom & Associates's biggest Q1 2019 reduction was Ellie Mae Inc, cutting an estimated $39.9M.
  • Van Berkom & Associates fully exited Maxar Technologies Inc. Common Stock in Q1 2019, selling an estimated $13.8M.
  • Van Berkom & Associates's ten largest holdings make up 32% of its $3.15B portfolio in Q1 2019.
  • Van Berkom & Associates opened 3 new positions and closed 2 in Q1 2019.
  • Van Berkom & Associates's portfolio value rose 11% quarter-over-quarter to $3.15B.

Based on Van Berkom & Associates's 13F filing for Q1 2019, filed 14 May 2019.